Anbieter: ThriftBooks-Dallas, Dallas, TX, USA
Hardcover. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Anbieter: WorldofBooks, Goring-By-Sea, WS, Vereinigtes Königreich
EUR 9,40
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.
Zustand: New. Editor(s): Chute, Anthony L.; Morgan, Christopher W.; Peterson, Robert A. Num Pages: 256 pages. BIC Classification: HRCC9; HRCX. Category: (G) General (US: Trade). Dimension: 231 x 156 x 16. Weight in Grams: 364. . 2013. First. Paperback. . . . . Books ship from the US and Ireland.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 27,33
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 256 pages. 8.90x5.90x0.70 inches. In Stock.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 31,16
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 303 pages. 8.75x6.00x0.75 inches. In Stock.
EUR 24,21
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Denominations, although often maligned, are important for the continued health and vitality of the church. Contributors from a variety of evangelical traditions share their personal stories for the sake of unity across denominational lines.Klappente.
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Neuware - Denominations. The word itself often sparks strong reactions, causing us to wonder if there are merits to our factions and if it's possible to come together as one.Showing how denominational affiliation can be natural without being negative, and how evangelical identity can help rather than hinder Christian unity, Why We Belong explains both the personal and doctrinal reasons each of the following contributors fit not only in their church, but also in the Church: Gerald L. Bray (Anglican) Timothy F. George (Baptist) Douglas A. Sweeney (Lutheran) Timothy C. Tennent (Methodist) Byron D. Klaus (Pentecostal) Bryan Chapell (Presbyterian)Demonstrating that Christians have significant reasons for identifying with a denomination, this book also helps us see and belong to something much larger than our own traditions--the family of God.
Sprache: Englisch
Verlag: Springer New York, Springer US, 2012
ISBN 10: 1461265479 ISBN 13: 9781461265474
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Cancer Informatics chronicles the development of the National Cancer Institute's new Cancer Informatics Infrastructure (CII) - an information management system infrastructure designed to faciliate clinical trials, provide for reliable, secure information exchange, and improve patient care. The book details the challenges involved in creating and managing such a knowledge base, including technologies, standards, and current, state-of-the-art applications.The ultimate goal of CII is to function as an enabler of clinical trials, expediting the clinical trials lifecycle, faciliating faster and safer drug development and more appropriate treatment choices for cancer patients. Contributors address the role the CII must play in converting the growing knowledge of genes, proteins, and pathways into appropriate preventative, diagnostic, and therapeutic measures. Presented in four sections, the first provides an overview of the processes involved in moving the infrastructure for cancer from theory into practice. Sections two through four offer the latest work done in the areas of technology, cancer-specific and national standards, and applications to faciliate clinical trials.
Sprache: Englisch
Verlag: Springer New York, Springer US Jan 2002, 2002
ISBN 10: 0387953280 ISBN 13: 9780387953281
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Buch. Zustand: Neu. Neuware -Cancer Informatics chronicles the development of the National Cancer Institute's new Cancer Informatics Infrastructure (CII) - an information management system infrastructure designed to faciliate clinical trials, provide for reliable, secure information exchange, and improve patient care. The book details the challenges involved in creating and managing such a knowledge base, including technologies, standards, and current, state-of-the-art applications.The ultimate goal of CII is to function as an enabler of clinical trials, expediting the clinical trials lifecycle, faciliating faster and safer drug development and more appropriate treatment choices for cancer patients. Contributors address the role the CII must play in converting the growing knowledge of genes, proteins, and pathways into appropriate preventative, diagnostic, and therapeutic measures. Presented in four sections, the first provides an overview of the processes involved in moving the infrastructure for cancer from theory into practice. Sections two through four offer the latest work done in the areas of technology, cancer-specific and national standards, and applications to faciliate clinical trials.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 408 pp. Englisch.
Sprache: Englisch
Verlag: Springer New York, Springer US, 2002
ISBN 10: 0387953280 ISBN 13: 9780387953281
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Cancer Informatics chronicles the development of the National Cancer Institute's new Cancer Informatics Infrastructure (CII) - an information management system infrastructure designed to faciliate clinical trials, provide for reliable, secure information exchange, and improve patient care. The book details the challenges involved in creating and managing such a knowledge base, including technologies, standards, and current, state-of-the-art applications.The ultimate goal of CII is to function as an enabler of clinical trials, expediting the clinical trials lifecycle, faciliating faster and safer drug development and more appropriate treatment choices for cancer patients. Contributors address the role the CII must play in converting the growing knowledge of genes, proteins, and pathways into appropriate preventative, diagnostic, and therapeutic measures. Presented in four sections, the first provides an overview of the processes involved in moving the infrastructure for cancer from theory into practice. Sections two through four offer the latest work done in the areas of technology, cancer-specific and national standards, and applications to faciliate clinical trials.